Clinical Trials Browser

Phase 1/2 × NETWORK × Doxorubicin × Clear all

NCT00098839 2017-12-12

Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)

Phase 1/2 Completed

134 enrolled 13 charts

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01495884 2015-10-26

The Myocet/Lapatinib Study. ICORG 10-03, V5

Phase 1/2 Terminated

Her2 Positive Metastatic Breast Cancer